Hybrid immunity from a combination of being vaccinated and previously infected with COVID-19 offers better protection against hospitalisation and severe infection than immunity simply from a previous infection, according to a new study in The Lancet. People with hybrid immunity were 97.4% less likely to be hospitalised or suffer severe infection at 12 months, whereas those […] Continue reading ->
The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading ->
As COVID-19 cases are starting to spike around the world once again, a new study published in The Lancet Respiratory Medicine “provides safety assurances to the global population” about fourth vaccine shots. The study, conducted in Israel, is the first large-scale research into the safety of the additional booster. It comes at the same time […] Continue reading ->
Gavi, the Vaccine Alliance, has pushed back on media reports that its board has decided to end COVID vaccine support for 37 middle-income countries next year – and end altogether the dedicated COVAX vaccine facility, supplying free vaccines to some 92 low- and middle-income countries, in 2024. A high-ranking official at Gavi told Health Policy […] Continue reading ->
The US Trade Representative’s (USTR) office announced on Tuesday that it supports extending the deadline on whether the World Trade Organization’s (WTO) Ministerial Decision on the TRIPS Agreement should be extended to COVID-19 diagnostics and therapeutics. Trade ministers adopted the Ministerial Decision on the TRIPS Agreement in June, giving members scope to diversify the production […] Continue reading ->